EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Metformin Blunts Vascular Insulin Sensitivity After Exercise Training in Adults at Risk for Metabolic Syndrome

Steven K Malin iD, Emily M Heiston, Daniel J Battillo, Tristan J Ragland, Andrew J Gow, Sue A Shapses, Ankit M Shah, James T Patrie iD, Eugene J Barrett

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgaf551 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Steven K Malin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Kinesiology and Health, Rutgers University, New Brunswick, NJ 08901, USA. Hauptthemen laut MEDLINE: Metformin, Metabolic Syndrome, Insulin Resistance, Exercise. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Metformin is the first-line pharmacotherapy for treating hyperglycemia, and it lowers cardiovascular disease risk. Prior work suggests that metformin can, however, interfere with metabolic adaptations to exercise. To date, no work has tested if metformin (Met) alters exercise training mediated vascular insulin sensitivity, and whether this is exercise intensity dependent.

Objective

This work aimed to test the hypothesis that Met blunts vascular insulin sensitivity in an intensity-based manner among adults at risk for metabolic syndrome.

Methods

In a double-blind, placebo-controlled trial, participants were randomly assigned to low-intensity exercise plus placebo (∼55% VO2max 5d/wk, LoEx + PL, n = 22) or metformin (2000 mg/d, LoEx + Met, n = 21) and high-intensity exercise plus placebo (∼85% VO2max 5d/wk, HiEx + PL, n = 24) or metformin (HiEx + Met, n = 24) for 16 weeks. A 120-minute euglycemic-hyperinsulinemic clamp (40 mU/m2/min, 90 mg/dL) was conducted pre and post treatment to assess macrovascular insulin sensitivity via brachial artery flow-mediated dilation (%FMD, conduit artery) as well as microvascular insulin sensitivity using contrast-enhanced ultrasound (eg, microvascular blood volume [MBV, perfusion] and microvascular blood flow [MBF]). Fasting and clamp-derived glucose, insulin, inflammatory measures (eg, endothelin-1 [ET-1], tumor necrosis factor α [TNF-α], soluble receptor for advanced glycation end products [sRAGE]), and nitric oxide (nitrite/nitrate) were assessed. Aerobic fitness (maximal oxygen consumption [VO2max]) and body composition (dual-energy x-ray absorptiometry [DXA]) were also analyzed.

Results

LoEx + PL and HiEx + PL increased VO2max (both P < .05), while there was no change after LoEx + Met or HiEx + Met. Body fat was reduced following HiEx + PL and HiEx + Met only (both P < .05). Met blunted the increase in insulin-stimulated FMDallometric and MBF seen with LoEx + PL and HiEx + PL (P < .05). Met also attenuated the reductions in fasting glucose, ET-1, and TNF-α compared with LoEx + PL and HiEx + PL (P < .05).

Conclusion

Met blunts exercise training-mediated increases in vascular insulin sensitivity at the levels of conduit arteries and capillaries, in parallel with altered inflammation and glycemic benefits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminMetabolic SyndromeInsulin ResistanceExerciseHypoglycemic AgentsHumansMaleFemaleDouble-Blind MethodAdultMiddle AgedBlood GlucoseGlucose Clamp Technique

Stichwörter der Autor:innen

endothelial functioninsulin resistancemicrovascular blood flowobesitytype 2 diabetes

Substanzen

MetforminHypoglycemic AgentsBlood Glucose

Autor:innen und Institutionen

  • Department of Kinesiology and Health, Rutgers University, New Brunswick, NJ 08901, USA.
  • Department of Medicine; Division of Endocrinology, Metabolism and Nutrition, Rutgers University, New Brunswick, NJ 08901, USA.
  • New Jersey Institute for Food, Nutrition and Health, Rutgers University, New Brunswick, NJ 08901, USA.
  • Institute of Translational Medicine and Science, Rutgers University, New Brunswick, NJ 08901, USA.
  • Department of Health, Human Performance, and Recreation, Pittsburg State University, Pittsburg, KS 66762, USA.
  • Department of Pharmacology, Rutgers University, Piscataway, NJ 08854, USA.

ORCID-Profile: Steven K Malin, James T Patrie

Förderung

  • NHLBI NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Malin, S. K., Heiston, E. M., Battillo, D. J., Ragland, T. J., Gow, A. J., Shapses, S. A., Shah, A. M., Patrie, J. T., & Barrett, E. J. (2025). Metformin Blunts Vascular Insulin Sensitivity After Exercise Training in Adults at Risk for Metabolic Syndrome. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf551

Vancouver

Malin SK, Heiston EM, Battillo DJ, Ragland TJ, Gow AJ, Shapses SA, et al. Metformin Blunts Vascular Insulin Sensitivity After Exercise Training in Adults at Risk for Metabolic Syndrome. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf551

BibTeX
@article{Malin2025,
  author = {Malin, Steven K and Heiston, Emily M and Battillo, Daniel J and Ragland, Tristan J and Gow, Andrew J and Shapses, Sue A and Shah, Ankit M and Patrie, James T and Barrett, Eugene J},
  title = {Metformin Blunts Vascular Insulin Sensitivity After Exercise Training in Adults at Risk for Metabolic Syndrome},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgaf551}
}
Kostenlos starten →